Current position:Home >Product >
2-[(5Z)-5-[(3-methoxy-4-phenylmethoxy-phenyl)methylidene]-4-oxidanylidene-2-sulfanylidene-1,3-thiazolidin-3-yl]butanedioic acid
2-[(5Z)-5-[(3-methoxy-4-phenylmethoxy-phenyl)methylidene]-4-oxidanylidene-2-sulfanylidene-1,3-thiazolidin-3-yl]butanedioic acid
|
|
Canonical SMILES:
COC1=C(C=CC(=C1)C=C2C(=O)N(C(=S)S2)C(CC(=O)O)C(=O)O)OCC3=CC=CC=C3
Isomeric SMILES
COC1=C(C=CC(=C1)/C=C\2/C(=O)N(C(=S)S2)C(CC(=O)O)C(=O)O)OCC3=CC=CC=C3
InChI
InChI=1S/C22H19NO7S2/c1-29-17-9-14(7-8-16(17)30-12-13-5-3-2-4-6-13)10-18-20(26)23(22(31)32-18)15(21(27)28)11-19(24)25/h2-10,15H,11-12H2,1H3,(H,24,25)(H,27,28)/b18-10-
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 2-[2-chloranyl-4-(5-oxidanylidene-6,7-dihydro-1H-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)phenoxy]-N-[3-(trifluoromethyl)phenyl]ethanamide
- (E)-1-phenyloct-1-en-3-one
- (4E)-4-[1-(3-chlorophenyl)-5-oxidanylidene-3-propyl-pyrazol-4-ylidene]-3-(3,5-dimethylpyridin-1-ium-1-yl)-1-(2-methoxyethyl)-5-oxidanylidene-pyrrol-2-olate
- 4-(piperidin-1-ylmethyl)-1,3,5,6,7,8-hexahydropyrimido[4,5-b]azepine-2-thione
- [2-(2,4-dimethylphenyl)-5-(4-fluorophenyl)pyrazol-3-yl]-[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]methanone
- ethyl 5-methyl-2-[(E)-2-(4-methylphenyl)ethenyl]-4-oxidanylidene-3H-thieno[2,3-d]pyrimidine-6-carboxylate
- (E)-3-(2,4-dichlorophenyl)-N-[3-[(4-methoxyphenyl)sulfamoyl]-4-methyl-phenyl]prop-2-enamide
- 1-[2-[(7E)-3-(4-methoxyphenyl)-7-[(4-methoxyphenyl)methylidene]-3a,4,5,6-tetrahydro-3H-indazol-2-yl]-2-oxidanylidene-ethyl]-5-(trifluoromethyl)pyridin-2-one
- 3-(1-adamantyl)-1-(4-nitrophenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]azepine
- (E)-2-(2,3-dihydroindol-1-ylcarbonyl)-3-[3-methoxy-4-[(2-methylphenyl)methoxy]phenyl]prop-2-enenitrile

